The ferroptosis inducer withaferin A and the CXCL10/CXCR2 axis inhibitor SB225002 can significantly restrain HCC metastasis and improve the prognosis of anti-PD-1 treatment[64]. The gene discussed is CXCR2; the disease is hepatocellular carcinoma.